Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.
Fill Out Your Profile to share more about you. Learn more...

AIs vs. Tamoxifen for Pre-Menopausal Women W/ Early-Stage, HR+

Study Compares Aromatase Inhibitors vs. Tamoxifen for Pre-Menopausal Women With Early-Stage, Hormone Receptor-Positive Breast Cancer
December 15, 2021

Pre-menopausal women diagnosed with early-stage, hormone receptor-positive breast cancer who took an aromatase inhibitor along with ovarian suppression after surgery had a 3.2% lower risk of recurrence than women who took tamoxifen after surgery. Still, there was no difference in overall survival. Read more...